Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome– paving the path towards precision medicine: a case report
Abstract Background Li-Fraumeni syndrome (LFS) is an autosomal dominant tumor predisposition syndrome characterized by a high familial incidence of various malignancies. It results from pathogenic/likely pathogenic heterozygous constitutional variants of the TP53 gene. Due to impaired DNA damage rep...
Saved in:
Main Authors: | Carolin Seeling, Sonja Dahlum, Ralf Marienfeld, Vera Jan, Brigitte Rack, Uwe Gerstenmaier, Ambros J. Beer, Regine Mayer-Steinacker, Wolfgang Thaiss, Thomas F. E. Barth, Thomas Seufferlein, Nadine T. Gaisa, Stephan Stilgenbauer, Wolfgang Janni, Reiner Siebert, Hartmut Döhner, Verena I. Gaidzik |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Journal of Cancer Research and Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00432-024-06077-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EGFR-Mutated Lung Adenocarcinoma With Li–Fraumeni Syndrome: The Imperative for Germline Testing in Patients With a Family History, a Case Report
by: Hiroyuki Fujii, MD, et al.
Published: (2025-02-01) -
Personalized screening strategies for TP53 R337H carriers: a retrospective cohort study of tumor spectrum in Li-Fraumeni syndrome adult carriersResearch in context
by: Pedro A.F. Galante, et al.
Published: (2025-02-01) -
Adrenal cortical carcinoma: Paediatric aspects – literature review
by: Patrycja Dasiewicz, et al.
Published: (2024-05-01) -
Pediatric Case of Li–Fraumeni Syndrome in Honduras
by: R. Martínez-Beckerat, et al.
Published: (2021-01-01) -
TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate
by: Paula Rofes, et al.
Published: (2025-01-01)